<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We evaluated hepatocyte paraffin 1 (HepPar1) antigen expression, a sensitive marker of small intestinal differentiation, in combination with morphologic features to demonstrate intestinal differentiation in cases equivocal for <z:hpo ids='HP_0100580'>Barrett esophagus</z:hpo> (BE) </plain></SENT>
<SENT sid="1" pm="."><plain>Clinicopathologic features and HepPar1 expression were recorded for 54 BE cases, 45 consistent with reflux <z:hpo ids='HP_0100633'>esophagitis</z:hpo> (RE) cases, and 65 "suspicious" for BE (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SBE</z:e>) cases </plain></SENT>
<SENT sid="2" pm="."><plain>The <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SBE</z:e> category included RE cases with 2 or more morphologic changes associated with BE or metaplastic reaction to injury (eg, multilayered epithelium, squamous islands, goblet cell mimickers, pancreatic <z:mpath ids='MPATH_160'>metaplasia</z:mpath>) </plain></SENT>
<SENT sid="3" pm="."><plain>HepPar1 was expressed in <z:hpo ids='HP_0000001'>all</z:hpo> 54 BE cases, 4 of 45 RE cases, and 24 of 65 SBE cases </plain></SENT>
<SENT sid="4" pm="."><plain>In <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SBE</z:e> cases, 2 or more morphologic changes were associated with HepPar1 expression in 37% of cases (24/65), 3 or more features in 59% (13/22), and 4 or more features in 100% (4/4) (P â‰¤ .004) </plain></SENT>
<SENT sid="5" pm="."><plain>The combination of certain morphologic changes and HepPar1 expression in clinically suspicious distal esophageal biopsy cases without goblet cells supports the presence of evolving <z:mpath ids='MPATH_167'>intestinal metaplasia</z:mpath> </plain></SENT>
</text></document>